Sep 26 |
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
|
Sep 26 |
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year?
|
Sep 20 |
ChromaDex appoints Ozan Pamir as CFO
|
Sep 20 |
ChromaDex Appoints Ozan Pamir as Chief Financial Officer
|
Sep 17 |
3 US Growth Companies With High Insider Ownership
|
Sep 15 |
Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company
|
Sep 10 |
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
|
Sep 9 |
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
|
Aug 23 |
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
|
Aug 20 |
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
|